Vectors TRIZ Cases

AAV8 mutant capsids employ specific point mutations to evade neutralizing antibodies while maintaining high transduction efficiency.

A bicistronic AAV vector delivers two siRNA cassettes to silence SOD1 in astrocytes and neurons.

Replacing triplet codons with quadruplets prevents unauthorized biological resource use without complex genome modifications.

Combining AUF1 vectors with microdystrophin stabilizes the sarcolemma to address inadequate treatments for dystrophinopathies.

A modified adenoviral vector incorporates serotype 45 hexon and fiber proteins to enhance gene delivery efficiency.

A 3300-4200 nucleotide stuffer sequence fills the adeno-associated virus genome, resolving heterogeneity from regulatory elements and improving virion purity.

Self-splicing introns enable efficient circular RNA production with reduced immunogenicity, avoiding expensive enzymatic catalysts.

A short PrSSL promoter sequence drives high protein expression levels in poxvirus vectors.

Stably integrated Rep and E2A genes eliminate transient transfection cytotoxicity, reducing DNA reagent costs while increasing viral titers.

A tag cassette enables specific detection and isolation of stem cells, resolving heterogeneity challenges in regenerative medicine.

Immediate early promoters drive antigen expression before vector antigens, reversing immunodominance hierarchies to boost CD8 T cell responses.

An inducible expression cassette uses an amino acid response element to drive precise gene transcription in host cells.

Engineered E. coli strains produce soluble recombinant proteins without N-terminal methionine residues.

Introducing non-native amino acids into adeno-associated virus capsid proteins increases transduction efficiency while reducing immunogenicity.

Expression cassettes integrate CTCF binding insulators with a truncated beta-globin locus control region to drive erythroid-specific gene transfer.

A recombinant adenovirus uses a microRNA-mediated gene regulatory system to detect circulating tumor cells.

A hybrid promoter combines COL2A1 and EF1α fragments to drive tissue-specific expression of type II collagen in bone cells.

Segmenting expression units with reverse orientation prevents non-uniform silencing while maintaining delivery efficiency.

Genetically engineered bacteria fix atmospheric nitrogen using modified promoter sequences to enhance expression levels in agricultural systems.

Recombinant AAV vector with modified periostin promoter drives gene expression in cardiac myofibroblasts.

Mini-intronic plasmid vectors incorporate bacterial elements within an intron to achieve persistent transgene expression.

Replacing native promoters with strong constitutive elements boosts lactotransferrin levels despite complex gene editing requirements.

Modified H5 promoter stabilizes antigen expression in recombinant MVA vaccines during serial passage, resolving genetic instability.

Combining a defined 5'UTR with an hCD33 leader resolves mRNA instability and folding errors to achieve four-fold higher yields.

A recombinant expression vector utilizes a hamster GAPDH promoter with a specific regulatory element to enhance protein production in mammalian host cells.

Artificial microRNAs selectively silence mutant myelin protein zero while codon-optimized DNA restores functional protein levels.

A regulatable adeno-associated virus vector integrates a gene switch system to control therapeutic molecule expression levels.

A nucleic acid sequence combines a histone stem-loop with a polyadenylation signal to boost protein expression levels.

A rodent model uses mouse probasin regulatory regions to drive prostate-specific expression of oncogenic proteins for targeted tumor development.

An inducible promoter system using erythritol and erythrulose regulatory regions enables precise gene expression control in yeast.

Lentiviral vector delivers truncated phenylalanine hydroxylase to hepatic cells.

Self-complementary AAV vectors bypass slow transduction by delivering alpha-sarcoglycan, reducing fibrosis and improving muscle force in muscular dystrophy.

Engineered rAAV genomes incorporating HLA-DR promoter elements compete for RFX transcription factors to dampen the humoral immune response.

Genetic inhibition of the VASH-SVBP complex lowers internal resistance in cardiomyocytes, improving contractility without increasing energy consumption.

Recombinant AAV vector delivers cardiac-specific PKP2 expression to restore heart muscle function.

An ACTA1-derived promoter achieves high skeletal muscle expression while avoiding cardiac toxicity associated with larger viral vectors.

A human ribosomal protein promoter drives high-level foreign gene expression in cultured mammalian host cells.

Engineered adeno-associated viral vectors traverse the blood-brain barrier to transduce specific neural cells with high efficiency.

Immediate early genes extend the productive window and maintain cell integrity during sustained baculovirus expression.

Inducible HPV-E6/E7 expression creates stable erythroid progenitor lines, resolving inefficient culturing periods and low yields in red blood cell production.

Barcoded adeno-associated virus vectors enable single-cell sequencing to identify transduced cells within heterogeneous populations.

Phenolic-inducible synthetic promoters resolve insufficient dynamic regulatory control by modulating enzyme expression via lignin degradation products.

Site-specific deamidation of AAVrh75 capsids evades preexisting immunity while expanding tissue tropism for gene therapy delivery.

Lentiviral vector transduces mesenchymal stem cells to co-express CXCR4 and IL-10, restoring homing receptor expression lost during ex vivo expansion.

Modified SIN lentiviral vectors utilize segmented chromatin insulators to enhance stable gene expression in hematopoietic stem cells.

A donor polynucleotide cassette with a 2A peptide enables targeted integration while preserving endogenous gene expression at the locus.

Splice control sequences mediate alternative splicing to achieve sex-specific and tissue-specific protein expression patterns.

An INSM1 promoter drives adenoviral vectors to express therapeutic genes selectively in neuroendocrine cells.

An adeno-associated virus vector restores desmosomal protein complexes in cardiomyocytes to treat right ventricular arrhythmogenic cardiomyopathy.

An attenuated glutamine synthetase selection marker enables stable cell line generation without methionine sulphoximine inhibitors.